NCT05782959 2023-03-24Phase 1 Study of BCD-245 in Subjects With NeuroblastomaBiocadPhase 1 Unknown24 enrolled
NCT02013336 2022-03-31Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid TumorsSouth Plains Oncology ConsortiumPhase 1 Unknown30 enrolled
NCT02457650 2016-08-03T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing MalignanciesShenzhen Second People's HospitalPhase 1 Unknown36 enrolled
NCT00101309 2013-12-18Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or NeuroblastomaNational Cancer Institute (NCI)Phase 1 Unknown10 enrolled
NCT00769613 2013-12-18Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsNational Cancer Institute (NCI)Phase 1 Unknown20 enrolled
NCT00314925 2010-02-25Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine FeaturesNeotropixPhase 1 Unknown60 enrolled